Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Khorkova

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Nature Biotechnology|March 1, 2017
Oligonucleotide therapies for disorders of the nervous systemOlga Khorkova, Claes Wahlestedt
Cellular and Molecular Neurobiology|July 14, 2020
Direct Administration and Gene Modulation Using Antisense Oligonucleotides Within the CNSClaes Wahlestedt, Olga Khorkova
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 10, 2007
Neuromodulators, not activity, control coordinated expression of ionic currentsOlga Khorkova, Jorge Golowasch
Frontiers in Molecular Biosciences|May 17, 2021
Nucleic Acid-Based Therapeutics in Orphan Neurological Disorders: Recent DevelopmentsOlga Khorkova, Jane Hsiao, Claes Wahlestedt
Drug Discovery Today. Therapeutic Strategies|January 13, 2015
Natural antisense transcripts as therapeutic targetsPaul Halley, Olga Khorkova, Claes Wahlestedt
Pharmaceutical Patent Analyst|November 19, 2013
Oligonucleotides for upregulating gene expressionOlga Khorkova, Jane Hsiao, Claes Wahlestedt
Expert Opinion on Drug Discovery|August 7, 2018
Developments in lncRNA drug discovery: where are we heading?Ilya Blokhin, Olga Khorkova, Jane Hsiao, et al.
Human Molecular Genetics|May 20, 2014
Natural antisense transcriptsOlga Khorkova, Amanda J Myers, Jane Hsiao, et al.
Frontiers in Genetics|September 4, 2023
Nucleic acid-based therapeutics for the treatment of central nervous system disordersRobyn McCartan, Olga Khorkova, Claude-Henry Volmar, et al.
Journal of Neurophysiology|July 4, 2008
Activity and neuromodulatory input contribute to the recovery of rhythmic output after decentralization in a central pattern generatorYili Zhang, Olga Khorkova, Rosa Rodriguez, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Nature Biotechnology|March 1, 2017
Oligonucleotide therapies for disorders of the nervous systemOlga Khorkova, Claes Wahlestedt
Cellular and Molecular Neurobiology|July 14, 2020
Direct Administration and Gene Modulation Using Antisense Oligonucleotides Within the CNSClaes Wahlestedt, Olga Khorkova
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 10, 2007
Neuromodulators, not activity, control coordinated expression of ionic currentsOlga Khorkova, Jorge Golowasch
Frontiers in Molecular Biosciences|May 17, 2021
Nucleic Acid-Based Therapeutics in Orphan Neurological Disorders: Recent DevelopmentsOlga Khorkova, Jane Hsiao, Claes Wahlestedt
Drug Discovery Today. Therapeutic Strategies|January 13, 2015
Natural antisense transcripts as therapeutic targetsPaul Halley, Olga Khorkova, Claes Wahlestedt
Pharmaceutical Patent Analyst|November 19, 2013
Oligonucleotides for upregulating gene expressionOlga Khorkova, Jane Hsiao, Claes Wahlestedt
Expert Opinion on Drug Discovery|August 7, 2018
Developments in lncRNA drug discovery: where are we heading?Ilya Blokhin, Olga Khorkova, Jane Hsiao, et al.
Human Molecular Genetics|May 20, 2014
Natural antisense transcriptsOlga Khorkova, Amanda J Myers, Jane Hsiao, et al.
Frontiers in Genetics|September 4, 2023
Nucleic acid-based therapeutics for the treatment of central nervous system disordersRobyn McCartan, Olga Khorkova, Claude-Henry Volmar, et al.
Journal of Neurophysiology|July 4, 2008
Activity and neuromodulatory input contribute to the recovery of rhythmic output after decentralization in a central pattern generatorYili Zhang, Olga Khorkova, Rosa Rodriguez, et al.
Pageof 3